Sio Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-28,400
Closed -$4.65M 71
2022
Q1
$4.65M Buy
+28,400
New +$4.68M 1.54% 18
2020
Q2
Sell
-20,858
Closed -$1.53M 85
2020
Q1
$1.53M Sell
20,858
-5,743
-22% -$499K 0.51% 43
2019
Q4
$2.24M Sell
26,601
-24,800
-48% -$1.92M 0.53% 41
2019
Q3
$4.32M Sell
51,401
-134,414
-72% -$10.2M 1.39% 26
2019
Q2
$12.2M Buy
185,815
+3,949
+2% +$228K 2.93% 7
2019
Q1
$10.7M Buy
181,866
+118,686
+188% +$7.09M 2.9% 8
2018
Q4
$3.34M Buy
+63,180
New +$3.47M 1.22% 37
2016
Q4
Sell
-116,053
Closed -$3.46M 47
2016
Q3
$3.46M Buy
+116,053
New +$3.39M 2.39% 15

Other funds holding MEDP

Sio Capital Management's MEDP Position: Q2 2022 in Review

Sio Capital Management sold out of Medpace (MEDP) in Q2 2022, closing a stake of 28,400 shares — an estimated $4.65M sold.

Sio Capital Management first reported a position in MEDP in Q3 2016 and held it in 8 quarters. The position peaked at $12.2M in Q2 2019. 338 funds tracked by Wall St. Rank hold MEDP as of Q2 2022.

  • Sio Capital Management reported no remaining Medpace position as of Q2 2022 after selling out during the quarter.
  • Sio Capital Management sold 28,400 Medpace shares in Q2 2022, an estimated $4.65M.
  • Sio Capital Management first reported a position in Medpace in Q3 2016 and held it in 8 quarters.
  • Sio Capital Management's Medpace position peaked at $12.2M in Q2 2019.
  • 338 funds tracked by Wall St. Rank held Medpace as of Q2 2022.

Based on Sio Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.